Literature DB >> 16579829

Compliance to surgical and radiation treatment guidelines in relation to patient outcome in early stage endometrial cancer.

Marieke A L van Lankveld1, Nicole C M Koot, Petra H M Peeters, Jules Schagen van Leeuwen, Ina M Jürgenliemk-Schulz, Marion A van Eijkeren.   

Abstract

RATIONALE, AIMS AND
OBJECTIVES: We evaluated the adherence to treatment guidelines in early stage endometrial cancer and the influence of adherence to guidelines on overall survival.
METHOD: Patients were identified in the central region in the Netherlands from 1990 till 1995. Patient and tumour characteristics, surgical findings, radiation and follow-up data were abstracted from medical records. Endpoint was overall survival. Kaplan-Meier method was used to perform time-to-event analysis. Hazard ratios for overall survival were estimated with a Cox Proportional Hazards model.
RESULTS: 359 patients were eligible for analysis. 335 patients presented with a clinical stage I cancer. 333 patients underwent a Total Abdominal Hysterectomy with Bilateral Salpingo Oophorectomy (TAH/BSO), of which 301 were staged as International Federation of Gynaecology and Obstetrics (FIGO) stage I, whereas 34 (10.2%) as FIGO stage II. Of the 24 patients with a clinical stage II cancer, 12 underwent a Radical Hysterectomy with Pelvic Lymph Node Dissection (RH/PLND), of which seven were diagnosed with FIGO stage II. In 72.1% of the patients adjuvant radiation was given or not in adherence to the guidelines. Whether treatment was given according to the guidelines or not did not affect 5 years overall survival.
CONCLUSION: This suggests that extensive surgical procedures are redundant in the treatment of occult stage II endometrial cancer.

Entities:  

Mesh:

Year:  2006        PMID: 16579829     DOI: 10.1111/j.1365-2753.2006.00618.x

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  5 in total

1.  Guideline-concordant endometrial cancer treatment and survival in the Women's Health Initiative Life and Longevity After Cancer study.

Authors:  Ashley S Felix; Eric M McLaughlin; Bette J Caan; David E Cohn; Garnet L Anderson; Electra D Paskett
Journal:  Int J Cancer       Date:  2019-10-31       Impact factor: 7.396

Review 2.  Lymphadenectomy for the management of endometrial cancer.

Authors:  Katie May; Andrew Bryant; Heather O Dickinson; Sean Kehoe; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

3.  Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.

Authors:  Mara Kaspers; Elyse Llamocca; Allison Quick; Jhalak Dholakia; Ritu Salani; Ashley S Felix
Journal:  Am J Obstet Gynecol       Date:  2020-03-03       Impact factor: 8.661

Review 4.  Lymphadenectomy for the management of endometrial cancer.

Authors:  Jonathan A Frost; Katie E Webster; Andrew Bryant; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2017-10-02

5.  Role of lymphadenectomy in intermediate-risk endometrial cancer: a matched-pair study.

Authors:  Pluvio J Coronado; Agnieszka Rychlik; Maria A Martínez-Maestre; Laura Baquedano; María Fasero; Aida García-Arreza; Sara Morales; Daniel M Lubian; Ignacio Zapardiel
Journal:  J Gynecol Oncol       Date:  2018-01       Impact factor: 4.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.